JILLIAN MARIANOS: Open Payments
NPI 1275266876 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 7 payments from 5 companies in 2025. Trend: 2023 $1,102 · 2024 $2,223 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 1 | $116 |
| Medtronic, Inc. | 2 | $54 |
| Actelion Pharmaceuticals US, Inc. | 1 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| Amgen Inc. | 1 | $25 |
Products named: FUROSCIX, SYMPLICITY G3, UPTRAVI, LEQVIO, REPATHA.
Industry payments across VA — which companies pay providers there.
